Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression

Cell. 2020 Jul 9;182(1):226-244.e17. doi: 10.1016/j.cell.2020.06.012.

Abstract

Lung cancer in East Asia is characterized by a high percentage of never-smokers, early onset and predominant EGFR mutations. To illuminate the molecular phenotype of this demographically distinct disease, we performed a deep comprehensive proteogenomic study on a prospectively collected cohort in Taiwan, representing early stage, predominantly female, non-smoking lung adenocarcinoma. Integrated genomic, proteomic, and phosphoproteomic analysis delineated the demographically distinct molecular attributes and hallmarks of tumor progression. Mutational signature analysis revealed age- and gender-related mutagenesis mechanisms, characterized by high prevalence of APOBEC mutational signature in younger females and over-representation of environmental carcinogen-like mutational signatures in older females. A proteomics-informed classification distinguished the clinical characteristics of early stage patients with EGFR mutations. Furthermore, integrated protein network analysis revealed the cellular remodeling underpinning clinical trajectories and nominated candidate biomarkers for patient stratification and therapeutic intervention. This multi-omic molecular architecture may help develop strategies for management of early stage never-smoker lung adenocarcinoma.

Keywords: APOBEC signature; MMP; carcinogen signature; genomics; lung cancer; non-smoker; phosphoproteomics; proteogenomics; proteomics; subtyping.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma of Lung / genetics
  • Adenocarcinoma of Lung / pathology
  • Asia, Eastern
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Carcinogens / toxicity
  • Cohort Studies
  • Cytosine Deaminase / metabolism
  • Disease Progression*
  • Gene Expression Regulation, Neoplastic
  • Gene Regulatory Networks
  • Genome, Human
  • Humans
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / pathology*
  • Matrix Metalloproteinases / metabolism
  • Mutation / genetics
  • Principal Component Analysis
  • Proteogenomics*
  • Smoking / genetics*

Substances

  • Biomarkers, Tumor
  • Carcinogens
  • Matrix Metalloproteinases
  • Cytosine Deaminase